Cargando…

Approach to the Diagnosis and Classification of Blood Cell Disorders

Detalles Bibliográficos
Autores principales:	Thachil, Jecko, Bates, Imelda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150139/ http://dx.doi.org/10.1016/B978-0-7020-6696-2.00023-0

Ejemplares similares

Approach to the diagnosis and classification of blood diseases
por: Bates, Imelda, et al.
Publicado: (2012)

Approach to the diagnosis and classification of blood diseases
por: Bates, Imelda, et al.
Publicado: (2006)

Haematological Diseases in the Tropics
por: Thachil, Jecko, et al.
Publicado: (2014)

Non‐factor therapies for bleeding disorders: A primer for the general haematologist
por: Swan, Dawn, et al.
Publicado: (2022)

The implications of aspirin resistance in renal failure
por: Thachil, Jecko
Publicado: (2008)

Abnormal coagulation tests before kidney biopsies—what next?
por: Thachil, Jecko
Publicado: (2013)

The difficult distinction between haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura
por: Thachil, Jecko
Publicado: (2008)

Usefulness of Combining D-Dimers with Thromboelastography
por: Thachil, Jecko
Publicado: (2020)

Lessons learnt from COVID‐19 coagulopathy
por: Thachil, Jecko
Publicado: (2021)

Hypoxia—An overlooked trigger for thrombosis in COVID‐19 and other critically ill patients
por: Thachil, Jecko
Publicado: (2020)

The versatile heparin in COVID‐19
por: Thachil, Jecko
Publicado: (2020)

The application of anticoagulant therapy to sepsis
por: Thachil, Jecko, et al.
Publicado: (2017)

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
por: Iba, Toshiaki, et al.
Publicado: (2017)

Differentiating biochemical from clinical heparin resistance in COVID-19
por: Lisman, Ton, et al.
Publicado: (2020)

Thromboprophylaxis in COVID-19 – Rationale and considerations
por: Bristogiannis, Sotirios, et al.
Publicado: (2021)

A proposal for staging COVID‐19 coagulopathy
por: Thachil, Jecko, et al.
Publicado: (2020)

Heparin – Messias or Verschlimmbesserung?
por: Swan, Dawn, et al.
Publicado: (2021)

Practical management of the haemorrhagic complications of myeloproliferative neoplasms
por: Jones, Edward, et al.
Publicado: (2022)

Anticoagulation in chronic kidney disease patients—the practical aspects
por: Hughes, Stephen, et al.
Publicado: (2014)

Coagulation abnormalities and thrombosis in patients with COVID-19
por: Levi, Marcel, et al.
Publicado: (2020)

Thromboembolism in nephrotic syndrome: controversies and uncertainties
por: Parker, Kathrine, et al.
Publicado: (2023)

The Comparison of the Protective Effects of α- and β-Antithrombin against Vascular Endothelial Cell Damage Induced by Histone in Vitro
por: Iba, Toshiaki, et al.
Publicado: (2017)

Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers
por: Gooding, Richard, et al.
Publicado: (2021)

UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based survey
por: Parker, Kathrine, et al.
Publicado: (2023)

Early Host Interactions That Drive the Dysregulated Response in Sepsis
por: Kerrigan, Steven W., et al.
Publicado: (2019)

Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential
por: Ito, Takashi, et al.
Publicado: (2019)

Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
por: Nielsen, Nathan D., et al.
Publicado: (2022)

Blood Transfusion
por: Bates, Imelda, et al.
Publicado: (2009)

New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey
por: Iba, Toshiaki, et al.
Publicado: (2017)

Proposal of the Definition for COVID-19-Associated Coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2021)

DIC in Pregnancy – Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments
por: Erez, Offer, et al.
Publicado: (2022)

Longitudinal Analysis of Prophylactic Anticoagulation in Primary Nephrotic Syndrome: Low Incidence of Thromboembolic Complications
por: McDonnell, Thomas, et al.
Publicado: (2023)

The unique characteristics of COVID-19 coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2020)

The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease
por: Lisman, Ton, et al.
Publicado: (2021)

The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis
por: Pérez-Casal, Margarita, et al.
Publicado: (2011)

Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients
por: Parker, Kathrine, et al.
Publicado: (2021)

Exploring the epidemiology of disseminated intravascular coagulation: protocol for the DANish Disseminated Intravascular Coagulation (DANDIC) Cohort Study
por: Flæng, Simon, et al.
Publicado: (2022)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
por: Thachil, Jecko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ikmmqe4mivdh4nm7va5hlkpvi